-
FDA announces AI rollout timeline and scientific review pilot completion
The FDA said its timing to scale use of AI inside its FDA centers follows the completion of a GenAI pilot for scientific review.
-
How much do we really know about AI in financial services?
Analysis of a recent Evident study of AI use in banks.
-
FSB report highlights need to minimise AI risk to financial stability
What are the implications of AI adoption in the financial sector? We take a look at the key findings from FSB’s latest report.
-
ECB unsure about publishing details of research into capital requirements for EU lenders
The study was compiled last year to counter mounting pressure from the banking sector.
-
What happens when a push for innovation collides with AI policy?
The opportunities offered by AI can be a test for constructing effective compliance and legal policies. We take a look at how to tackle the conundrum.
-
Do better on managing AI risk, says Dutch Data Protection Authority
New AI report from Autoriteit Persoonsgegevens suggests setting a comprehensive AI strategy for Netherlands.
-
What you need to do as the EU AI Act gets a green light
A deal-readiness and compliance roadmap for dealing with the long-awaited proposals.
-
Pathways to progress: Intelligent design for an AI world
How UK financial regulators will supervise firms seeking to deploy AI.